RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $741,000 | -3.5% | 134,400 | +69.5% | 0.00% | +100.0% |
| Q4 2021 | $768,000 | -32.7% | 79,300 | +24.3% | 0.00% | -50.0% |
| Q3 2021 | $1,141,000 | -23.0% | 63,800 | +5.1% | 0.00% | -33.3% |
| Q2 2021 | $1,482,000 | -7.9% | 60,700 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,609,000 | +342.0% | 60,700 | +26.7% | 0.00% | +200.0% |
| Q4 2020 | $364,000 | +34.8% | 47,900 | -11.1% | 0.00% | 0.0% |
| Q3 2020 | $270,000 | -30.6% | 53,900 | -17.2% | 0.00% | 0.0% |
| Q2 2020 | $389,000 | +47.3% | 65,100 | +9.6% | 0.00% | 0.0% |
| Q1 2020 | $264,000 | -47.0% | 59,400 | +13.4% | 0.00% | 0.0% |
| Q4 2019 | $498,000 | +21.2% | 52,400 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $411,000 | -47.3% | 52,400 | +5.6% | 0.00% | -50.0% |
| Q2 2019 | $780,000 | +164.4% | 49,600 | +204.3% | 0.00% | +100.0% |
| Q1 2019 | $295,000 | +45.3% | 16,300 | +29.4% | 0.00% | 0.0% |
| Q4 2018 | $203,000 | -32.8% | 12,600 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $302,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |